Cargando…
d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19
Since the outbreak of coronavirus disease 2019 (COVID-19), biomarkers for evaluating severity, as well as supportive care to improve clinical course, remain insufficient. We explored the potential of d-amino acids, rare enantiomers of amino acids, as biomarkers for assessing disease severity and as...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584837/ https://www.ncbi.nlm.nih.gov/pubmed/36280155 http://dx.doi.org/10.1016/j.bbadis.2022.166584 |